Cesar E. Ercole
YOU?
Author Swipe
View article: Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study
Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study Open
Triage Plus demonstrated clinical validity in veteran patients with hematuria, with improved sensitivity and specificity compared with earlier assays.
View article: Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease Open
Background Personalized genomic classifiers have transformed the management of prostate cancer (PCa) by identifying the most aggressive subsets of PCa. Nevertheless, the performance of genomic classifiers to risk classify African American …
View article: Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the <scp>V</scp>an<scp>DAAM</scp> study
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the <span>V</span>an<span>DAAM</span> study Open
Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cance…
View article: Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer Open
Purpose To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC). Materials and methods We analyzed data from 1105 patients with MIBC. Patients age was evalu…
View article: MP06-09 THE IMPACT OF AGENT ORANGE EXPOSURE ON BLADDER CANCER
MP06-09 THE IMPACT OF AGENT ORANGE EXPOSURE ON BLADDER CANCER Open
You have accessJournal of UrologyBladder Cancer: Epidemiology & Evaluation I1 Apr 2018MP06-09 THE IMPACT OF AGENT ORANGE EXPOSURE ON BLADDER CANCER Michael Risk, Vikram Narayan, and Cesar Ercole Michael RiskMichael Risk More articles by th…
View article: FR-22 FROM "END OF UROLOGY" TO ENDOUROLOGY: UROLOGIC LEGACY OF THE THE MINNEAPOLIS VA
FR-22 FROM "END OF UROLOGY" TO ENDOUROLOGY: UROLOGIC LEGACY OF THE THE MINNEAPOLIS VA Open
You have accessJournal of UrologyHistory Forum1 Apr 2018FR-22 FROM "END OF UROLOGY" TO ENDOUROLOGY: UROLOGIC LEGACY OF THE THE MINNEAPOLIS VA Giulia Lane, Maria Uloko, Vikram Narayan, and Cesar Ercole Giulia LaneGiulia Lane More articles b…
View article: MP58-04 DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3-4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE
MP58-04 DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3-4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE Open
You have accessJournal of UrologyBladder Cancer: Invasive V1 Apr 2017MP58-04 DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3-4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE Homayoun Zargar, Jay B Shah, Elisabeth E…
View article: Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer Open
Objective: Sarcopenia, or the age-related loss of skeletal muscle mass and function, has been investigated as a potential marker of adverse outcomes among surgical patients. Our aim was to assess for changes in psoas muscle volume (PMV) fo…